Skip to main content
. 2012 Apr 12;104(9):690–699. doi: 10.1093/jnci/djs189

Table 1.

Characteristics of prostate cancer case patients (n = 1260)*

Characteristic Case patients
Age at blood collection (y), mean (SD) 64.4 (7.8)
Age at diagnosis (y), mean (SD) 69.5 (7.5)
Stage, No. (%)
    T1, T2 (N0, M0) 1010 (86)
    T3a (N0, M0) 92 (8)
    T3b (N0, M0) 43 (4)
    T4 (N0, M0) 1 (0)
    N1 15 (1)
    M1 15 (1)
Gleason grade, No. (%)
    2 to 6 646 (56)
    7: 3 + 4 or no major score defined 275 (24)
    7: 4 + 3 110 (9)
    8 to 10 129 (11)
Deaths or metastases due to prostate cancer, No. (%) 114 (9)
    Prostate cancer deaths without recorded date of metastasis 68
    Metastases to bone or organs on follow-up 31
    Metastases at diagnosis 15
Time to diagnosis from blood draw (y), median (IQR) 5.2 (2.9–7.5)
Time to lethal prostate cancer (death or metastases) from diagnosis (y), median (IQR) 5.2 (3.1–8.4)
*

IQR = interquartile range; SD = standard deviation.

Data for stage missing for 84 subjects.

Data for Gleason grade missing for 100 subjects.